Certified by Founder Lodge
Braveheart Bio
United States - San Francisco, California
START UP
1 Disclosed Funding Rounds $185,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 06 ,2025 | Series A | $185,000,000 |
Enavate Sciences
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
